therascreen ® EGFR RGQ PCR Kit to guide treatment with AstraZeneca's lung cancer drug in U.S. QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today received U.S. marketing (PMA) approval of ...
Venlo, the Netherlands, Nov. 09, 2023 (GLOBE NEWSWIRE) -- QIAGEN (QGEN) (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three new kits for use on its QIAcuity systems and a ...
Venlo, the Netherlands, July 18, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the expansion of its digital PCR (dPCR) offering for the development of ...
QIAGEN N.V. QGEN recently announced the expansion of its digital PCR (dPCR) offering for the biopharma sector's cell and gene therapy development in partnership with Niba Labs. The recent development ...
VENLO, the Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR ...
The government of Saudi Arabia is evaluating the solution for its potential to contain the virus during the Mecca pilgrimage. Qiagen has launched an influenza A/H1N1 test and several updates to its ...
Breast cancer is the most frequently occurring form of cancer in women. Whilst 5-year survival rates for localized disease approach 99%, cases of advanced breast cancer have a much poorer prognosis, ...
* QIAGEN NV SAYS RECEIVED CLEARANCE FOR ITS IPSOGEN JAK2 RGQ PCR KIT FROM U.S. FDA FOR ADDITIONAL USE IN DIAGNOSIS OF ALL MYELOPROLIFERATIVE NEOPLASMS Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results